Navigation Links
Anastrozole Is A More Effective Cancer Drug

The NHS of the UK has come under increased pressure from charities for making it possible to increase access to a new breast cancer drug which is better than tamoxifen//. Women suffering from the early stages of the disease are treated with tamoxifen. If the women who were treated with tamoxifen for two years were to switch over to anastrozole, one of the new drugs, they are more likely to be alive after a period of two and a half years, according to the research.

In the case of the patients who had switched drugs, the deaths had gone down by 29%. The study was conducted on over 4,000 women across Italy, Germany, and Australia. The deaths among the 2,009 women who changed over to anastrozole was 66, while in the case of tamoxifen, it was 90.

AstraZeneca is marketing anastrozole as Arimidex, and this has received the support of the NHS in Scotland. Tamoxifen administered over 5 years after initial surgery brought down the recurrence of breast cancer by 50%, and administering anastrozole reduces it by a further 26%.

In the UK alone as many as 32,000 postmenopausal women are diagnosed with breast cancer every year, and as three quarters of the tumors are due to sex hormone oestrogen, they are ideal for the new treatment. Arimidex belongs to the aromotase inhibitors class of drugs which prevents the further development of oestrogen.

The treatment costs £68 per month, and it is very much more expensive than tamoxifen. Aromatase inhibitors prevent estrogen and also do not increase the possibilities of endometrial cancer and blood clots. The three brands of this medicine are Novartis Pharmaceuticals’ Femara, Pfizer Inc.’s Aromasin and AstraZeneca PLC’s Arimidex
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
Breaking Medicine Technology: